Biologics manufacturers can use a recently developed mathematical model that has been developed to identify problems with recombinant protein expression during the antibody manufacturing process.  Image credit: Flickr user UCL Mathematical and Physical  Science As the world grows ever more dependent on biologics, ensuring the quality of the manufacturing process […]

As it turns out, a healthy gut is something people will pay a lot of money for. The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015 and is expected to grow to $63.8 billion in 2021.1 There has been a rise in reported cases of issues such as Celiac’s disesase, irritable bowel, inflammatory bowel disease (IBD) and Crohn’s, which necessitates the need for better and more varied medication.

Page 12 of 95« First...1011121314...203040...Last »